98%
921
2 minutes
20
Manual tissue decellularization is an onerous process that requires the application of many sequential treatments by an operator and can be prone to user error and result variability. While automated decellularization devices have been previously reported, with advances being made in recent years toward open-source platforms, previous automated decellularization devices have been reliant on hardware or software components that are closed-source and proprietary. The aim of the current work was to develop and validate a full open-source automated decellularization system to be available for others to adopt. The open-source decellularization apparatus is a low-cost (<$2000) device that may easily be adapted to an array of decellularization protocols, with an example parts' list provided herein. The automated decellularization device was used to decellularize hyaline cartilage, knee meniscus, and tendon tissues. Cartilage, meniscus, and tendon tissue demonstrated 97%, 99%, and 96% reduction in DNA content after decellularization, respectively, and with effective decellularization confirmed visually via histology. High retentions of glycosaminoglycans (GAGs), collagen, and other proteins were observed in meniscus and tendon following decellularization. Results with manual decellularization with meniscus tissue were consistent with the automated decellularization process. Decellularized cartilage (DCC) demonstrated a 34% decrease in GAG content, while the protein and collagen content did not significantly change. The current study demonstrated that native-like decellularized tissues were produced reproducibly using the reported open-source automated decellularization platform, providing an adoptable platform for production of decellularized tissues by others. Impact statement Decellularized extracellular matrix (ECM)-based materials are appealing for tissue engineering, but production of these materials is historically time-intensive, tedious, and prone to user error. Adoption of an automated system may be a barrier for many research groups due to cost and complexity. In this article, a low-cost open-source platform for automated decellularization is presented. This method is validated by decellularizing porcine musculoskeletal tissues and demonstrating the native-like compositional properties of these decellularized tissues. The ability to produce decellularized tissue in an automated manner is useful for further research of ECM-based materials and potential clinical applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/ten.TEC.2022.0005 | DOI Listing |
RSC Adv
August 2025
Centre for Mechanical Technology Automation (TEMA), Department of Mechanical Engineering, University of Aveiro Aveiro Portugal
Notwithstanding the demonstrated benefits of electrical stimulation in enhancing tissue functionality, existing state-of-the-art electrostimulation systems often depend on invasive electrodes or planar designs. This work exploits the versatility of graphene to fabricate biocompatible electrodes for the three-dimensional electrical stimulation of neural stem cells. A conductive green graphene-based ink was formulated and screen-printed as the bottom and top electrodes in a bottom-less standard culture well plate.
View Article and Find Full Text PDFBiomater Sci
August 2025
Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, 5016 Emerging Technologies Building, 5032 Emerging Technologies Building, College Station, TX 77843, USA.
models aim to improve biomimicry of tissues and disease processes. Decellularized extracellular matrix (dECM) scaffolds mimic cellular interactions with 3D tissue architecture. These complex 3D models require parallel advancements in analytical methods to quantify functional outputs with respect to scaffold architecture and recellularization while retaining spatial integrity.
View Article and Find Full Text PDFBiomater Adv
July 2025
Lampe Joint Department of Biomedical Engineering, North Carolina State University/ University of North Carolina-Chapel Hill, Raleigh, NC, USA; Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA. Electronic address:
Vocal fold (VF) fibrosis, often resulting from phonosurgery, radiation, or trauma, causes irreversible voice dysfunction due to excessive ECM deposition and increased tissue stiffness. No FDA-approved treatments for VF fibrosis exist, highlighting the need for novel antifibrotic therapies. TGF-β1 contributes to fibroblast-to-myofibroblast activation, leading to increased ACTA2 expression and collagen production via SMAD3, YAP1, and integrin signaling pathways.
View Article and Find Full Text PDFBiofabrication
July 2025
School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, NO.66, Gongchang Road, Shenzhen 518107, Guangdong, People's Republic of China.
Colorectal cancer is a prominent global malignancy that highlights the pressing need for reliable preclinical models to expedite therapeutic efficacy and drug discovery. Traditional models, such as cell lines and patient-derived xenografts, are constrained by their inability to fully replicate tumor heterogeneity and support scalable drug screening. While patient-derived organoids more accurately preserve tumor pathophysiology, their clinical translation is impeded by technical challenges related to standardization, reproducibility, and high-throughput compatibility.
View Article and Find Full Text PDFCurr Transplant Rep
May 2025
Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC USA.
Purpose Of The Review: Despite recent advancements in technology for the treatment of type 1 diabetes (T1D), exogenous insulin delivery through automated devices remains the gold standard for treatment. This review will explore progress made in pancreatic islet bioengineering within the field of beta-cell replacement for T1D treatment.
Recent Findings: First, we will focus on the use of decellularized extracellular matrices (dECM) as a platform for pancreatic organoid development.